Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Pending
Company Name
Biolex, Inc.
Proposed Ticker
BLEX
CUSIP
N/A
Business Description
A clinical-stage biopharmaceutical company that uses our patented LEX System to develop hard-to-make therapeutic proteins and optimized monoclonal antibodies.
Lead Underwriter
Lehman Brothers, Deutsche Bank Securities
Co-Managers
Leerink Swann & Company
Initial Shares
N/A
Revised Initial Shares
N/A
Initial Price
N/A
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
